Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved..
BACKGROUND: There are significant correlations between the levels of tumor infiltrating lymphocytes (TILs) and the prognosis of primary breast cancer. While little is known about immunological mechanisms in the distant metastasis of advanced breast cancer.
PATIENTS AND METHODS: A total of 106 patients with advanced metastatic breast cancer were enrolled in this study between 2016 and 2022. Hematoxylin and eosin staining and immunohistochemistry were used to assess the densities of stromal TILs (sTILs), intratumoral TILs (iTILs) and invasive marginal TILs (imTILs) and CD4+, CD8+, CD20+, FOXP3+ TILs in the primary tumor and metastasis (bone, lung, liver, and distant lymph node) of advanced breast cancer.
RESULTS: Higher levels of sTILs at metastatic sites were associated with better progression-free survival (PFS), postmetastasis survival (PMS) and overall survival (OS) (p = .026, .001 and .005, respectively). The levels of iTILs were significantly lower than those of sTILs and imTILs in both primary tumor (p< .001, both) and metastasis (p< .001, both). The level of CD4+ T cells was higher than those of CD8+ T cells and CD20+ B cells in both primary tumor (p < .001) and metastasis (p < .001). The levels of sTILs (p=0. 001) and imTILs (p< .001) in the primary tumor were generally higher than those in the metastasis.
CONCLUSION: The levels of TILs and their subsets can predict the survival and prognosis of patients with advanced breast cancer. The distributions of TILs and their subsets are similar between the primary tumor and metastasis. The metastases have a lower degree of lymphocytes infiltration than its corresponding primary tumor.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Clinical breast cancer - 24(2024), 3 vom: 11. Apr., Seite e167-e176 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sun, Xin-Yi [VerfasserIn] |
---|
Links: |
---|
Themen: |
CD20 |
---|
Anmerkungen: |
Date Completed 26.03.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.clbc.2023.12.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367027429 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367027429 | ||
003 | DE-627 | ||
005 | 20240405233359.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clbc.2023.12.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n1366.xml |
035 | |a (DE-627)NLM367027429 | ||
035 | |a (NLM)38212189 | ||
035 | |a (PII)S1526-8209(23)00327-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sun, Xin-Yi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.03.2024 | ||
500 | |a Date Revised 04.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: There are significant correlations between the levels of tumor infiltrating lymphocytes (TILs) and the prognosis of primary breast cancer. While little is known about immunological mechanisms in the distant metastasis of advanced breast cancer | ||
520 | |a PATIENTS AND METHODS: A total of 106 patients with advanced metastatic breast cancer were enrolled in this study between 2016 and 2022. Hematoxylin and eosin staining and immunohistochemistry were used to assess the densities of stromal TILs (sTILs), intratumoral TILs (iTILs) and invasive marginal TILs (imTILs) and CD4+, CD8+, CD20+, FOXP3+ TILs in the primary tumor and metastasis (bone, lung, liver, and distant lymph node) of advanced breast cancer | ||
520 | |a RESULTS: Higher levels of sTILs at metastatic sites were associated with better progression-free survival (PFS), postmetastasis survival (PMS) and overall survival (OS) (p = .026, .001 and .005, respectively). The levels of iTILs were significantly lower than those of sTILs and imTILs in both primary tumor (p< .001, both) and metastasis (p< .001, both). The level of CD4+ T cells was higher than those of CD8+ T cells and CD20+ B cells in both primary tumor (p < .001) and metastasis (p < .001). The levels of sTILs (p=0. 001) and imTILs (p< .001) in the primary tumor were generally higher than those in the metastasis | ||
520 | |a CONCLUSION: The levels of TILs and their subsets can predict the survival and prognosis of patients with advanced breast cancer. The distributions of TILs and their subsets are similar between the primary tumor and metastasis. The metastases have a lower degree of lymphocytes infiltration than its corresponding primary tumor | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CD20 | |
650 | 4 | |a CD4 | |
650 | 4 | |a CD8 | |
650 | 4 | |a FOXP3 | |
650 | 4 | |a TILs | |
650 | 4 | |a Tumor microenvironment | |
700 | 1 | |a Wang, Cheng-Qin |e verfasserin |4 aut | |
700 | 1 | |a Mao, Yan |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Zhen-Qi |e verfasserin |4 aut | |
700 | 1 | |a Cui, Jian |e verfasserin |4 aut | |
700 | 1 | |a Dong, Xian-Ning |e verfasserin |4 aut | |
700 | 1 | |a Wang, Hai-Bo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical breast cancer |d 2000 |g 24(2024), 3 vom: 11. Apr., Seite e167-e176 |w (DE-627)NLM11782898X |x 1938-0666 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:3 |g day:11 |g month:04 |g pages:e167-e176 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clbc.2023.12.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 3 |b 11 |c 04 |h e167-e176 |